References
- An K, Sun Y, Xu L, Cui X. 2011. Preparation and in vitro evaluation of simvastatin ethosome. Artif Cells Blood Substit Immobil Biotechnol. 39:347–350.
- Baigude H, Su J, McCarroll J, Rana TM. 2013. In vivo delivery of RNAi by reducible interfering nanoparticles (iNOPs). ACS Med Chem Lett. 4:720–723.
- Du B, Li Y, Li X, A Y, Chen C, Zhang Z. 2010. Preparation, characterization and in vivo evaluation of 2-methoxyestradiol-loaded liposomes. Int J Pharm. 384:140–147.
- Gao J, Liu W, Xia Y, Li W, Sun J, Chen H, et al. 2011. The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes. Biomaterials. 32:3459–3470.
- Gao J, Yu Y, Zhang Y, Song J, Chen H, Li W, et al. 2012. EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials. 33:270–282.
- Kim MJ, Lee HJ, Lee IA, Kim IY, Lim SK, Cho HA, Kim JS. 2008. Preparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomes. Arch Pharm Res. 31:539–546.
- Kogure K, Moriguchi R, Sasaki K, Ueno M, Futaki S, Harashima H. 2004. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J Control Release. 98:317–323.
- Obata Y, Suzuki D, Takeoka S. 2008. Evaluation of cationic assemblies constructed with amino acid based lipids for plasmid DNA delivery. Bioconjug Chem. 19:1055–1063.
- Shi ML, Zhao ZH, Wang Y, Chen HP. 2009. In vivo delivery of siRNA. Herditas. 31: 683–688.
- Whitehead KA, Langer R, Anderson DG. 2009. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 8:129–138.
- Zhou Y, Wei YH, Zhang GQ, Wu XA. 2010. Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir. Arch Pharm Res. 33:567–574.